Egypt's EIPICO to supply COVID-19 medicine to 11 countries

The agreement was approved by the concerned authorities in Egypt and Belarus

  
A lab technician wearing a full-face mask and a protective suit works on investigational coronavirus disease (COVID-19) treatment drug "Favipiravir" at Eva Pharma Facility in Cairo, Egypt June 25, 2020.

A lab technician wearing a full-face mask and a protective suit works on investigational coronavirus disease (COVID-19) treatment drug "Favipiravir" at Eva Pharma Facility in Cairo, Egypt June 25, 2020.

REUTERS/Amr Abdallah Dalsh

Cairo –  The Egyptian International Pharmaceutical Industries (EIPICO) signed a cooperation agreement with World Medicine to supply 100,000 remdesivir vials, the COVID-19 antiviral medication, to 11 countries.

The countries include Russia, Ukraine, Kazakhstan, Uzbekistan, Moldova, Belarus, Kurdistan, Tajikistan as well as Poland, Czech, and Slovakia, according to a bourse disclosure on Wednesday.

The agreement was approved by the concerned authorities in Egypt and Belarus.

In July, EIPICO’s Chairman, Ahmed El-Kilany, said that the company would start manufacturing remdesivir in the beginning of August to be supplied in mid-August.

During the first nine months of 2020, EIPICO achieved net profits of EGP 339.46 million, down from EGP 522.19 million in the year-ago period.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From North Africa